Kamud Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 10-12-2024
- Paid Up Capital ₹ 1.59 Cr
as on 10-12-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.50 Cr
as on 10-12-2024
- Satisfied Charges ₹ 49.37 Cr
as on 10-12-2024
- Revenue -100.00%
(FY 2023)
- Ebitda 69.29%
(FY 2023)
- Net Worth -0.23%
(FY 2023)
- Total Assets 4.54%
(FY 2023)
About Kamud Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.59 Cr.
The company currently has active open charges totaling ₹13.50 Cr. The company has closed loans amounting to ₹49.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhijeet Konduskar and Supriya Konduskar serve as directors at the Company.
- CIN/LLPIN
U24232MH1988PTC048793
- Company No.
048793
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kamud Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeet Konduskar  | Managing Director | 25-Dec-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Supriya Konduskar | Director | 30-Sep-2010 | Current |
Financial Performance of Kamud Drugs.
Kamud Drugs Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kamud Drugs?
Unlock access to Kamud Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Konduskar Sugars Private LimitedActive 13 years 11 monthsAbhijeet Konduskar and Supriya Konduskar are mutual person
- Konduskar Laboratories Private LimitedActive 18 years 5 months
Abhijeet Konduskar and Supriya Konduskar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Mar 2009 | ₹13.50 Cr | Open |
The Shamrao Vithal Co-Operative Bank Limited Creation Date: 23 Apr 2012 | ₹8.50 Cr | Satisfied |
The Shamrao Vithal Co-Operative Bank Limited Creation Date: 23 Apr 2012 | ₹4.85 Cr | Satisfied |
How Many Employees Work at Kamud Drugs?
Unlock and access historical data on people associated with Kamud Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kamud Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamud Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
